In addition to the robust reduction in collagen synthesis, the authors also reported slight changes in levels of TGF-β receptor1 and smad3, a downstream signaling molecule in the TGF-β pathway, in SPARC siRNA treated cells, although changes in the levels of these proteins in siRNA-treated cells did not reach statistical significance [ 56 ].
1
—
—